Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Appendix Table 6. Characteristics of Included Studies (continued)


Study & Year
(Reference)
JADADb
Was the study described as randomized (this includes words such as randomly, random, and randomization)?

0 or 1
JADADb
Was the method used to generate the sequence of randomization described and appropriate (table of random numbers, computer-generated, etc)?

0 or 1
JADADb
Was the study described as double blind?

0 or 1
JADADb
Was the method of double blinding described and appropriate (identical placebo, active placebo, dummy, etc)?

0 or 1
JADADb
Was there a description of withdrawals and dropouts?

0 or 1
JADADb
Method used to generate the sequence of randomization was described and it was inappropriate (patients were allocated alternately, or according to date of birth, hospital number, etc). Deduct 1

0 or -1
JADADb
Study was described as double blind but the method of blinding was inappropriate (e.g., comparison of tablet vs. injection with no double dummy). Deduct 1

0 or -1
Total Jadad Score
(0-5)
Kekki, 200148 1 1 1 1 0 0 0 4
Kurkinen-Räty, 200049 1 1 1 0 1 0 -1 3
Odendaal, 200250 1 1 0 0 1 0 0 3
Guaschino, 200351 1 0 0 0 1 0 0 2
Kiss, 200452 1 1 0 0 1 0 0 4
Lamont, 2003531 1 1 1 1 0 0 5
Larsson, 2006541 1 1
(blinding similar to Kiss et al., 200452)
0 1 0 0 4

Abbreviations: BV, bacterial vaginosis; NA, not applicable; NICU, neonatal intensive care unit; NR, not reported; NS, not significant; PTD, preterm delivery; Tx, treatment.
b. Quality assessment items from the Jadad Scale.

Return to Document
Proceed to Next Section

 

AHRQ Advancing Excellence in Health Care